|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/19/2024 |
$0.50 |
$0.61 |
$0.45 |
$0.53 |
1.01M | 04/22/2024 |
$0.54 |
$0.58 |
$0.51 |
$0.54 |
367.50K | 04/23/2024 |
$0.54 |
$0.56 |
$0.51 |
$0.53 |
169.70K | 04/24/2024 |
$0.52 |
$0.56 |
$0.52 |
$0.55 |
201.90K | 04/25/2024 |
$0.55 |
$0.56 |
$0.52 |
$0.53 |
274.20K |
|
BrainStorm Cell Therapeutics is a biotechnology company engaged in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases including: Amyotrophic Lateral Sclerosis; Progressive Multiple Sclerosis; Alzheimer's disease; and other neurodegenerative diseases. NurOwn®, Co.'s proprietary cell therapy platform, utilizes cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival and improve neurological function. | |
|
Brainstorm Cell Therapeutics (BCLI) has the following price history information. Looking back at BCLI historical stock prices for the last five trading days, on April 19, 2024, BCLI opened at $0.50, traded as high as $0.61 and as low as $0.45, and closed at $0.53. Trading volume was a total of 1.01M shares. On April 22, 2024, BCLI opened at $0.54, traded as high as $0.58 and as low as $0.51, and closed at $0.54. Trading volume was a total of 367.50K shares. On April 23, 2024, BCLI opened at $0.54, traded as high as $0.56 and as low as $0.51, and closed at $0.53. Trading volume was a total of 169.70K shares. On April 24, 2024, BCLI opened at $0.52, traded as high as $0.56 and as low as $0.52, and closed at $0.55. Trading volume was a total of 201.90K shares. On April 25, 2024, BCLI opened at $0.55, traded as high as $0.56 and as low as $0.52, and closed at $0.53. Trading volume was a total of 274.20K shares.
BCLI Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Brainstorm Cell Therapeutics shares, starting with a $10,000 purchase of BCLI, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$0.29 |
|
End price/share: |
$0.53 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
82.76% |
|
Average Annual Total Return: |
6.22% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$18,280.63 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/19/2024 | $0.53 | 04/22/2024 | $0.54 | 04/23/2024 | $0.53 | 04/24/2024 | $0.55 | 04/25/2024 | $0.53 |
|
|